Pharmaceuticals
Pharmaceuticals encompass the research, development and manufacturing of drugs for disease treatment and prevention by applying chemistry, pharmacology and medical science. Effective medications and therapies are critical to enhancing patient health outcomes. These medications continue to improve based on growing knowledge of biochemical processes and drug interactions.
Top Stories
-
News
04 Jun 2025
FDA launches gen AI Elsa to support clinical, regulatory tasks
The FDA is scaling up the rollout of Elsa, an in-house generative AI tool designed to assist with clinical protocol reviews, adverse event summaries and internal data tasks. Continue Reading
-
Podcast
02 Jun 2025
FDA ends GLP-1 compounding for semaglutide, tirzepatide
The FDA’s decision to end temporary compounding permissions for GLP-1 drugs like semaglutide and tirzepatide pushes patients into insurance and prescription challenges. Continue Reading
-
News
07 Mar 2022
UC Berkeley Loses CRISPR Gene-Editing Patent Appeal
After an eight-year-long legal battle over the commercial application of CRISPR gene editing, PTAB’s decision rocked UC Berkeley and biotech companies that originally licensed the technology. Continue Reading
-
News
03 Mar 2022
FDA Accepts Bristol Myers’s BLA for Non-Small Cell Lung Cancer Drug
FDA based its decision on Phase 3 trial results, which showed that the non-small cell lung cancer drug plus chemotherapy improved complete response and event-free survival in patients. Continue Reading
-
News
03 Mar 2022
FDA Accepts Application for Pfizer’s Biosimilar to Humira
A study of the interchangeable biosimilar Abrilada met its primary goal of pharmacokinetic equivalence in patients who switched between treatment with Abrilada and Humira. Continue Reading
-
News
02 Mar 2022
Nearly Half of All Medicare Drug Prices Increased From 2019-2020
Among the 1,947 Medicare-covered drugs with price increases above the inflation rate in 2020, one-third saw price increases of 7.5 percent or more, the current annual inflation rate. Continue Reading
-
News
28 Feb 2022
GSK Introduces Standalone Consumer Healthcare Company, Haleon
GSK and Pfizer proposed to combine their consumer healthcare business into a world-leading joint venture in 2019. Now, the companies will deploy Haleon in over 100 markets globally. Continue Reading
-
News
25 Feb 2022
Top-Selling Medicare Part D Prescription Drugs in Recent Years
Prescription drugs were not covered for Medicare beneficiaries before 2006. Now, the top-selling Medicare Part D drugs of all time include Revlimid, Eliquis, Xarelto, Trulicity, and Humira. Continue Reading
-
News
24 Feb 2022
GSK, Sanofi Seek Approval of COVID-19 Vaccine for Adults
In other COVID news, Novavax announces the first shipments of COVID-19 vaccine to EU member states and Australia grants provisional registration to Moderna’s vaccine. Continue Reading
-
News
24 Feb 2022
Lilly Launches Campaign to Educate Early Breast Cancer Patients
The collaboration campaign provides educational materials and other resources for individuals with certain types of breast cancers and their care partners. Continue Reading
-
News
22 Feb 2022
FDA Grants Emergency Authorization For Eli Lilly’s COVID-19 Antibody
In other COVID news, WHO grants Roche’s Actemra prequalification for COVID-19 in adults and Gilead’s COVID-19 treatment was well tolerated in pediatric patients. Continue Reading
-
News
17 Feb 2022
Bristol Myers Grants $7.9M to Improve Access to Care Across US
The health equity grants will increase access to care and support diversity, cultural competency, and collaboration among community health workers across the US. Continue Reading
-
News
17 Feb 2022
Gilead’s COVID-19 Treatment Effective Against Variants of Concern
In other COVID news, Moderna supplies 10.8-million doses of its COVID-19 vaccine to Colombia and the Siemens Healthineers COVID-19 antigen self-test is now available in the US. Continue Reading
-
News
15 Feb 2022
Senate Confirms Robert Califf as FDA Commissioner
The Senate narrowly confirms Robert Califf as FDA Commissioner after the Biden Administration’s nearly ten month-long battle to nominate him. Continue Reading
-
News
10 Feb 2022
Samsung Biologics to Accelerate Growth in Biosimilar Research
Samsung Biologics will acquire full ownership of Samsung Bioepis to further its streamlined operational efficiencies and boost its biosimilar and therapeutic research growth. Continue Reading
-
News
09 Feb 2022
Pfizer Seeks to Amend EUA of COVID-19 Vaccine to Include Children
The expanded authorization would include the first two COVID-19 vaccine doses of a planned three-dose primary series in children six months to four years old. Continue Reading
-
News
09 Feb 2022
FDA Approves Takeda’s Von Willebrand Disease Treatment
Other recent FDA Approvals include a T-cell receptor for adults with unresectable or metastatic uveal melanoma and insomnia treatment. Continue Reading
-
News
07 Feb 2022
CHMP Issues Positive Opinion of Pfizer’s COVID-19 Treatment
In other COVID news, Novavax and Israel entered into an agreement to supply Novavax’s COVID-19 vaccine in Israel and Daiichi Sankyo initiates a trial to study its vaccine booster in Japan. Continue Reading
-
News
03 Feb 2022
Patient, Prescription-Related Factors Linked to Opioid Overdose
The JAMA study found that patient and prescription-related factors can help guide clinicians during a patient’s opioid overdose experience. Continue Reading
-
News
03 Feb 2022
FDA Approves Label Update for CAR-T Cell Therapy, Yescarta
Yescarta is now the first and only chimeric antigen receptor (CAR) T-cell therapy with information on the label to help treat patients with large B-cell lymphoma. Continue Reading
-
News
02 Feb 2022
Former Head of Pharmaceutical R&D of Roche Joins Pfizer
William Pao will oversee Pfizer’s global product development organization and be responsible for the clinical development and advancement of the company’s pipeline. Continue Reading
-
News
02 Feb 2022
FDA Grants Full Approval of Moderna’s COVID-19 Vaccine
In other COVID news, Novavax submits an emergency use authorization request to FDA for its COVID-19 vaccine and Merck’s COVID-19 treatment is proven effective against Omicron. Continue Reading
-
News
01 Feb 2022
Eli Lilly Invests $1B in Facility to Boost Access to Medicine in NC
The facility will utilize the latest technology to manufacture Eli Lilly and Company’s injectable products to increase access to medicine in North Carolina. Continue Reading
-
News
31 Jan 2022
Regeneron Gets FDA Review for Non-Small Cell Lung Cancer Treatment
Regeneron’s non-small cell lung cancer treatment, Libtayo, is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T-cells. Continue Reading
-
News
28 Jan 2022
2020 Drug Price Increase Driven by Generic Drugs, Biosimilars
The Vizient 2022 Pharmacy Market Outlook found that the overall estimated drug price inflation rate will be 3.09% due to high-cost medications, generic drugs to market, and biosimilars. Continue Reading
-
News
27 Jan 2022
FDA Expedites Approval of Gilead’s COVID-19 Treatment, Remdesivir
In other COVID news, FDA revises the authorization for two monoclonal antibody treatments and Pfizer initiates a clinical trial to study a new Omicron-based vaccine candidate. Continue Reading
-
News
27 Jan 2022
FDA Grants Clearance to Biotricity’s Arrhythmia Monitoring Device
The device addresses the current limitation of existing Holter monitors and creates a revenue stream with a simplified workflow to lower turnaround time and risk for patients and providers. Continue Reading
-
News
25 Jan 2022
Pharmacists’ Role to Expand to Direct Patient Care by 2030
Pharmacists’ role will continue to evolve over the next decade despite the shortage of doctors and nurses and as complex new therapies are developed. Continue Reading
-
News
24 Jan 2022
Cosette Acquires 8 Prescription Medications from Daiichi Sankyo
The transaction adds eight prescription medications focused on cardiovascular indications to Cosette Pharma’s current portfolio of over 45 commercial products. Continue Reading
-
News
21 Jan 2022
Pfizer’s COVID-19 Treatment Shows In Vitro Efficacy Against Omicron
In other COVID news, Merck and UNICEF expand access to its COVID-19 treatment to low- and middle-income countries and Australia grants provisional registration for Novavax’s vaccine. Continue Reading
-
News
19 Jan 2022
Tony Wood Replaces Hal Barron as GSK’s Chief Executive Officer
As chief executive officer of GSK, Wood will assume full responsibility for research and development across the company’s portfolio and pipeline from August 2022. Continue Reading
-
News
18 Jan 2022
Pfizer’s COVID-19 Vaccine, Pneumococcal Vaccine Helps Older Adults
Pfizer recently announced positive top-line results from a Phase 3 trial studying its COVID-19 vaccine combined with its pneumococcal 20-valent conjugate vaccine, Prevnar 20. Continue Reading
-
News
07 Jan 2022
Big Pharma Cooperation Advances Digital Measures, Drug Development
Industry cooperation to boost digital measures and focus on a more “patient-first” approach helps bring effective drugs to market for patients more quickly. Continue Reading
-
News
06 Jan 2022
FDA Expands MRI Compatibility for XR Spinal Cord Stimulation
FDA’s new labeling lifts MRI restrictions for lead tip locations and radiofrequency power used as part of the standard operating mode of an MRI scan. Continue Reading
-
News
06 Jan 2022
FDA Authorizes Siemens Healthineers COVID-19 Antigen Self-Test
In a recent study, the CLINITEST Rapid COVID-19 Antigen Self-Test demonstrated sensitivity of 86.5% and a specificity of 99.3% compared to the PCR detection method. Continue Reading
-
News
05 Jan 2022
FDA Approves Two Pediatric Indications For J&J’s Xarelto
Xarelto now has 11 indications in the US, the most of any direct oral anticoagulant (DOAC), and is the most studied oral FactorXa inhibitor in its class. Continue Reading
-
News
05 Jan 2022
iQ Group Seeks Approval for Diabetes Care Management Biosensor
The real-time biosensor is a small, organic, thin-film transistor diagnostic test that detects accurate salivary glucose measurement for diabetes care management. Continue Reading
-
News
04 Jan 2022
FDA Expands Authorization for Pfizer’s COVID-19 Vaccine Booster
FDA amended the authorization for the COVID-19 vaccine booster to include children 12 and older two months after expanding the authorization to include individuals 18 years and older. Continue Reading
-
News
03 Jan 2022
Biogen to Reduce Price of Alzheimer’s Disease Treatment by 50%
For a patient of average weight, the annual cost at the maintenance dose of the Alzheimer’s disease treatment will be $28,200. Continue Reading
-
News
30 Dec 2021
FDA Sends Warning Letter to Medtronic About Diabetes Business
The warning letter focused on the inadequacy of the requirements in risk assessment, corrective and preventive action, complaint handling, device recalls, and reporting of adverse events. Continue Reading
-
News
29 Dec 2021
FDA Issues Emergency Authorization for Merck’s COVID-19 Treatment
In a Phase 3 trial, 6.8% of patients who received molnupiravir were hospitalized or died before the 29-day follow-up, compared to 9.7% of patients who received placebo. Continue Reading
-
News
28 Dec 2021
Pharma Execs Site Supply Chain Visibility To Boost Manufacturing
Enhancing supply chain visibility can alleviate product loss and security concerns, boost quality assurance, replace outdated IT systems, and lower costs. Continue Reading
-
News
27 Dec 2021
Pfizer to Amend Clinical Study of COVID-19 Vaccine in Children
In other COVID news, AstraZeneca’s COVID-19 antibody neutralizes Omicron variant and the European Commission approved GSK’s COVID-19 antibody. Continue Reading
-
News
23 Dec 2021
FDA Approves ViiV Healthcare’s Long-Acting Injectable for HIV
In addition to ViiV’s long-acting injectable to treat HIV, recent FDA approvals include a myasthenia gravis treatment and AstraZeneca and Amgen’s asthma treatment. Continue Reading
-
News
22 Dec 2021
FDA Approves Pfizer’s Drug to Treat Adult Patients With AS
FDA approves Pfizer’s tofacitinib for AS patients. The drug is the first and only oral JAK inhibitor approved in the US for five indications. Continue Reading
-
News
17 Dec 2021
CHMP Issues Positive Opinion of J&J’s COVID-19 Vaccine Booster
In other COVID news, Pfizer re-confirms the efficacy of its COVID-19 vaccine booster shot and GSK and Sanofi’s COVID-19 booster elicits strong immune responses in a clinical trial. Continue Reading
-
News
15 Dec 2021
SAGE, WHO Support Johnson & Johnson COVID-19 Vaccine Booster
In a Phase 3 trial, J&J’s COVID-19 vaccine booster provided 100 percent protection at least 14 days post-final vaccination and 75 percent protection against symptomatic COVID-19 globally. Continue Reading
-
News
14 Dec 2021
Moderna Launches Artificial Intelligence Academy for mRNA Therapies
The initiative will educate Moderna employees to integrate artificial intelligence and machine learning solutions into every system and process. Continue Reading
-
News
14 Dec 2021
GSK Welcomes Gavi Decision to Fund Routine Malaria Vaccines for Kids
GSK’s malaria vaccine, RTS,S/AS01 e, is the first and only malaria vaccine to significantly reduce malaria in children in pivotal long-term clinical trials. Continue Reading
-
News
08 Dec 2021
FDA Approves Imaging Drug to Identify Ovarian Cancer
FDA approves Cytalux to improve the ability to locate additional ovarian cancerous tissue that is generally difficult to detect. Continue Reading
-
News
07 Dec 2021
J&J Considers Licensing COVID-19 Vaccine to South African Company
The agreement would allow for the first manufacturing and distribution of a COVID-19 vaccine sold by an African company for people living in Africa. Continue Reading
-
News
06 Dec 2021
CVS Health Initiatives Increase Affordability, Access To Medicine
CVS Health announces several steps to support its strategy to make healthcare more convenient, affordable, and accessible. Continue Reading
-
News
06 Dec 2021
Specialty Drugs Accounted for Half of Medicaid Spending in 2020
Magellan Health’s trend report found that specialty drugs, including Mavyret and Trikafta, made up 51.4% of Medicaid spending last year. Continue Reading
-
News
02 Dec 2021
FDA Addresses Impacts of New Variant, Urges COVID-19 Vaccinations
FDA is actively evaluating the potential impacts of the new COVID variant on currently available vaccines and urges COVID-19 vaccinations or booster shots. Continue Reading
-
News
01 Dec 2021
Johnson & Johnson Evaluates COVID-19 Vaccine Against New Variant
In other COVID news, Moderna updates its strategy to address the new variant, Omicron, and Thermo Fisher finds that two of its COVID-19 tests detect Omicron. Continue Reading
-
News
30 Nov 2021
GSK Appoints Phil Dormitzer Global Head of Vaccines, Research
Dormitzer will report to Hal Barron, chief scientific officer and president of research and development of GSK. Continue Reading
-
News
29 Nov 2021
FDA Approves First Treatment for Children with Achondroplasia
In a Phase 3 study, patients receiving the achondroplasia drug grew an average of 1.57 centimeters taller than those receiving a placebo. Continue Reading
-
News
29 Nov 2021
CVS, Walgreens & Walmart Helped Fuel Opioid Crisis in Ohio Counties
The Ohio counties blamed CVS, Walgreens, and Walmart for not doing enough to stop the flow of prescription pills that caused an opioid crisis and cost each county about $1B. Continue Reading
-
News
23 Nov 2021
CDC Expands COVID-19 Vaccine Booster Shots To All Americans
The CDC stated that all Americans 18 years and older who have completed the primary series “should” get a COVID-19 vaccine booster shot of an FDA authorized vaccine. Continue Reading
-
News
23 Nov 2021
US Gov’t Purchases 10M Courses of Pfizer’s COVID-19 Antiviral
In other COVID news, AstraZeneca’s COVID-19 antibody reduced the risk of developing symptomatic virus by 83% and the EMA began evaluating Novavax’s application for its vaccine. Continue Reading
-
News
22 Nov 2021
FDA Grants Designation For Early-Stage Breast Cancer Blood Test
In previous studies, Datar Cancer Genetics’ blood test detected Stage 0 and Stage 1 breast cancers with high accuracy. Continue Reading
-
News
19 Nov 2021
FDA Expands Pfizer’s COVID-19 Vaccine Booster Authorization
FDA expands emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine booster shot to include individuals 18 years of age and older. Continue Reading
-
News
19 Nov 2021
FDA Approves Rare Blood Disease Injection For Adults
Two individual studies found that after 7.5 years of treatment with Besremi 61% of patients with the rare blood disease polycythemia vera saw a complete hematological response. Continue Reading
-
News
18 Nov 2021
Improved Diagnostic Testing Boosts Patient Experience, Study Finds
Abbott’s Beyond Intervention research program finds a growing demand for an industry-wide standard in diagnostic testing to optimize the patient experience. Continue Reading
-
News
18 Nov 2021
Pfizer, BioNTech, Zipline Deliver First COVID-19 Vaccines in Ghana
The first long-range drone delivery will allow for the distribution of nearly 50,000 doses of the Pfizer-BioNTech COVID-19 vaccine in Ghana. Continue Reading
-
News
15 Nov 2021
Abbott, ADA Initiative Addresses Diabetes Care Management in POC
This is the first initiative under the ADA’s Health Equity Now platform to address diabetes care management in people of color. The program will launch in Columbus, Ohio. Continue Reading
-
News
15 Nov 2021
J&J Increases Access To Its COVID-19 Vaccine Through COVAX
In other COVID news, the Japanese govt purchases 1.6M courses of Merck’s COVID-19 treatment and Moderna asks the EU to expand its COVID-19 vaccine to children 6 to 11 years of age. Continue Reading
-
News
12 Nov 2021
President Biden Nominates Former FDA Commissioner as Head of FDA
Former FDA commissioner, Robert Califf, will lead FDA and play a vital role in policy ambitions and manage the scrutiny of FDA’s drug approval process. Continue Reading
-
News
12 Nov 2021
CHMP Recommends Approval Of Roche’s COVID-19 Antibody Combination
The committee recommends the approval of Roche’s COVID-19 antibody combination based on positive data from Phase 3 trials, which found that the drug reduced risk of death by 20%. Continue Reading
-
News
10 Nov 2021
Merck’s COVID-19 Treatment Receives First Authorization in UK
The UK based its decision on the Phase 3 trial that found Merck’s COVID-19 treatment reduced the risk of hospitalization or death by nearly 50% in COVID-19 patients. Continue Reading
-
News
08 Nov 2021
FDA Approves Novartis’ Chronic Myeloid Leukemia Treatment
Novartis’ Scemblix is the first FDA-approved chronic myeloid leukemia treatment that binds to the ABL myristoyl pocket. Continue Reading
-
News
08 Nov 2021
CDC Recommends Pfizer- BioNTech COVID-19 Vaccine for Children
The CDC expands COVID-19 vaccine recommendations to nearly 28 million children for children five to 11 years of age in the US. Continue Reading
-
News
04 Nov 2021
Feds Purchases More Doses of Lilly’s COVID-19 Antibody Treatment
In other COVID news, the government purchases 50 million more doses of Pfizer’s COVID-19 vaccine and FDA needs more time to complete Moderna’s EUA request for its vaccine in adolescents. Continue Reading
-
News
03 Nov 2021
Novartis, Global Heart Hub to Combat Cardiovascular Disease
Novartis and Global Health Hub have unveiled a program aimed at reducing cardiovascular disease-related death. Continue Reading
-
News
02 Nov 2021
FDA Authorizes Thermo Fisher’s COVID-19 New Test Collection Method
Thermo Fisher can now run COVID-19 tests from saliva samples collected with the Spectrum Solutions SpectrumDNA SDNA-1000 collection device on the Amplitude Solution. Continue Reading
-
News
01 Nov 2021
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children
FDA based its decision on a Phase 2/3 trial that found two doses of the Pfizer-BioNTech COVID-19 vaccine to 90.7% effective in preventing COVID-19 in children aged five to 11. Continue Reading
-
News
28 Oct 2021
FDA Accepts Application for Novartis’ Diabetic Macular Edema Drug
FDA based its decision on the KITE and KESTREL trials, which studied Novartis’ diabetic macular edema drug in 926 patients in 36 countries. Both trials met their primary endpoint. Continue Reading
-
News
28 Oct 2021
New Pilot to Leverage API, AI for Enhanced Diagnostic Accuracy
The new interface will allow provider organizations and other healthcare technology companies to bring VisualDx’s CDS into third-party applications to boost overall diagnostic accuracy. Continue Reading
-
News
25 Oct 2021
FDA Approves Expansion of Gilead’s HIV Drug in Pediatric Patients
FDA approves a new low-dose tablet dosage form of Gilead’s HIV drug for younger children living with the disease. Continue Reading
-
News
22 Oct 2021
CDC Unanimously Recommends J&J, Moderna COVID-19 Vaccine Booster
CDC unanimously recommends a booster dose of the Johnson & Johnson and Moderna COVID-19 vaccines one day after FDA approval. Continue Reading
-
Answer
22 Oct 2021
CVS Health Says Pharmacists Key for Medication Adherence, Access
CVS Health works to empower pharmacists to become more involved in patient care, including boosting medication adherence, allowing for a more personalized and proactive approach to care. Continue Reading
-
News
21 Oct 2021
FDA Authorizes Moderna, J&J Booster COVID-19 Vaccine Dose
FDA grants emergency use authorization for both Moderna and Johnson & Johnson’s COVID-19 vaccine booster doses based on the totality of scientific evidence. Continue Reading
-
News
21 Oct 2021
FDA Approves Interchangeable Biosimilar for Inflammatory Diseases
The approval is the second interchangeable product that FDA has approved and the first interchangeable biosimilar to treat certain inflammatory diseases. Continue Reading
-
News
20 Oct 2021
FDA Approves First Treatment for Rare Disease Congenital Athymia
FDA based its approval on clinical studies, which found that the rare disease drug significantly improved survival of children with congenital athymia. Continue Reading
-
News
19 Oct 2021
FDA Recommends Booster Dose of Moderna’s COVID-19 Vaccine
An FDA committee unanimously voted to recommend the booster dose for adults at least six months following the primary series. Continue Reading
-
News
18 Oct 2021
FDA Recommends Authorization For J&J’s COVID-19 Vaccine Booster
FDA committee votes 19-0 to recommend the COVID-19 vaccine booster dose to adults two months after initial vaccination. Continue Reading
-
News
18 Oct 2021
Roche Receives Breakthrough Therapy for Alzheimer’s Disease
FDA based its decision on recent data from the ongoing SCarlet RoAD and Marguerite RoAD trials, which showed that Roche’s drug reduced a pathological hallmark of Alzheimer’s disease. Continue Reading
-
News
13 Oct 2021
Moderna to Build State-of-the-Art mRNA Facility in Africa
Moderna will invest nearly $500 million in the new facility, expected to include drug substance manufacturing with fill/finish and packaging capabilities at each site. Continue Reading
-
News
12 Oct 2021
FDA Grants Designation For Daiichi Sankyo’s Breast Cancer Treatment
FDA granted the designation based on data from a Phase 3 trial in which Enhertu reduced the risk of disease progression or death in HER2 positive breast cancer patients by 72%. Continue Reading
-
News
12 Oct 2021
J&J’s Chief Scientific Officer Paul Stoffels Announces Retirement
Paul Stoffels, who spearheaded the development of the Johnson & Johnson COVID-19 vaccine, will retire at the end of 2021. Continue Reading
-
News
11 Oct 2021
ViiV Healthcare Submits FDA Application for HIV Regimen
If approved, ViiV Healthcare’s single-tablet regimen will broaden the treatment options available for children living with HIV. Continue Reading
-
News
08 Oct 2021
Marketing Strategies to Boost Access to Prescription Medications
While individuals most often go to a drug store or pharmacy for prescription medications, mail-orders and online prescription services have increased over the past few years. Continue Reading
-
News
07 Oct 2021
FDA Approves Kite’s CAR T-Cell Therapy For Leukemia
Other recent FDA approvals include a rare liver disease drug for pruritus and AbbVie’s episodic migraine drug. Continue Reading
-
News
06 Oct 2021
FDA Approves Amgen’s Repatha for Autosomal Dominant Disease
FDA approved Repatha for pediatric patients with autosomal dominant disease, heterozygous familial hypercholesterolemia, as an adjunct to diet and other LDL-C lowering therapies. Continue Reading
-
News
05 Oct 2021
Francis Collins Resigns as Director of the NIH After 12 Years
Collins is the longest-serving presidentially appointed NIH director, serving three US presidents over 12 years. Continue Reading
-
News
30 Sep 2021
Eli Lilly and Company to Drop Insulin Costs 40% in the US
The new list price of the company’s insulin, effective January 2022, will be $82.41 for individual vials and $159.12 for a pack of five pens. Continue Reading
-
News
24 Sep 2021
COVID-19 Treatment Remdesivir Reduces Hospitalizations by 87%
In other COVID news, Canada approves Moderna’s COVID-19 vaccine and Pfizer and BioNTech will supply more vaccine doses to the US for donation to low-and lower-middle-income countries. Continue Reading
-
News
22 Sep 2021
Thermo Fisher Launches Enzyme Analyzers for Assay Applications
Thermo Fisher launches two enzyme analyzer systems to deliver fully automated incubation settings, reagent additions, and precise measurement calculations. Continue Reading
-
News
16 Sep 2021
Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
In other COVID news, Novavax launches a clinical trial of its combination COVID-19/ flu vaccines and Takeda will manufacture 150M doses of Novavax’s COVID-19 vaccine in Japan. Continue Reading
-
News
14 Sep 2021
Thermo Fisher Launches Portfolio to Advance Quantitative Analysis
The new mass spectrometry portfolio will boost quantitative analysis, increase workflow throughput through polarity speeds, and boost sensitivity for key target applications. Continue Reading
-
News
09 Sep 2021
FDA Approves Johnson & Johnson’s Schizophrenia Injectable
Other recent FDA approvals include Merck’s Keytruda for bladder cancer and BeiGene’s Brukinsa to treat adult patients with Waldenström’s macroglobulinemia. Continue Reading
-
News
08 Sep 2021
Novartis Boosts Access to Cholesterol-Lowering RNA Therapy
Novartis and NHS England will boost access to the RNA therapy for patients across England who have persistently elevated LDL cholesterol levels and a history of certain cardiovascular events. Continue Reading